Suppr超能文献

宫颈癌根治性经阴道子宫切除术联合腹膜外盆腔淋巴结清扫术

Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.

作者信息

Savino L, Borruto F, Comparetto C, Massi G B

机构信息

Department of Gynaecology, Perinatology and Human Reproduction, University of Florence, Italy.

出版信息

Eur J Gynaecol Oncol. 2001;22(1):31-5.

Abstract

OBJECTIVE

The aim of this work was to examine three types of radical vaginal hysterectomy with different degrees of radicality, performed in order to reduce surgical complications and sequelae in different indications, and to test the feasibility of a new simple and quick technique for extraperitoneal pelvic lymphadenectomy to be used in combination with radical vaginal hysterectomy for treatment of cervical cancer. In this way the advantages of vaginal surgery (e.g.: unnecessary general anaesthesia, reduced surgical trauma, applicability to obese and poor surgical risk patients, fast time-saving procedure) can be preserved.

METHODS

We compared retrospectively the long-term results of radical vaginal and radical abdominal operations in a large series of stage IB-IIA cervical cancer patients treated at our institution in Florence from 1968 to 1983. Furthermore, we analysed the results of our experience from 1995 to 1998, when we performed extraperitoneal pelvic lymphadenectomy, followed by radical vaginal hysterectomy, on 48 patients affected by cervical cancer. Extraperitoneal pelvic lymphadenectomy was performed through two small abdominal incisions (6-7 cm). Twenty-two patients (45%) were obese (BMI>30 kg/m2) and 20 were poor surgical risks. FIGO stage was: IB1 in 18 cases, IB2 in eight, IIA in six, IIB in 12, IIIB in four. Neoadjuvant chemotherapy was given in 12 cases and preoperative irradiation was given in ten. General and regional anaesthesia were used in 30 (62.5%) and in 18 (37.5%) cases, respectively.

RESULTS

As for past experience, in stage IB the five-year survival of 356 patients who underwent radical vaginal hysterectomy and that of 288 who had radical abdominal hysterectomy with pelvic lymphadenectomy were 81% and 75%, respectively (p<0.05). Surgical complications were fewer with no mortality in the first group. In stage IIA, survival rates were 68% for radical vaginal hysterectomy and 64% for radical abdominal hysterectomy, in 76 and 64 cases, respectively (p=n.s.). As for the more recent experience, median operative time for extraperitoneal pelvic lymphadenectomy was 20 minutes for each side (range 15-36). In each patient a median of 26 lymph nodes were removed (range 16-48). Positive nodes were found in 12 cases (25%). Median operative time for radical vaginal hysterectomy was 40 minutes (range 30-65). Extraperitoneal pelvic lymphadenectomy complications included: lymphocyst, five cases (10%) and retroperitoneal hematoma, one (2%); all occurred at the beginning of the experience. Radical vaginal hysterectomy complications included: ureteral stenosis, one (2%) and uretero-vaginal fistula, one (2%). All complications occurred in patients who received radiotherapy or chemotherapy preoperatively. Median hospital stay was ten days (range 6-20).

CONCLUSIONS

The results of our work demonstrate that our technique for extraperitoneal pelvic lymphadenectomy shows a good applicability to cervical cancer patients submitted to radical vaginal hysterectomy, which has a high rate of cure for stage IB and IIA as shown by our past experience. The procedure of extraperitoneal pelvic lymphadenectomy was quick, easy, and safe, and its realization was not detrimental to the advantages of radical vaginal hysterectomy. Our experience supports the continued use of this combined extraperitoneal and vaginal approach in the treatment of cervical cancer. Moreover, the three classes of radical vaginal hysterectomy allow tailoring the type of the operation to the clinical and physical characteristics of the patients.

摘要

目的

本研究旨在探讨三种不同根治程度的根治性阴道子宫切除术,以减少不同适应证下的手术并发症和后遗症,并测试一种新的简单快速的腹膜外盆腔淋巴结清扫术与根治性阴道子宫切除术联合用于治疗宫颈癌的可行性。通过这种方式,可以保留阴道手术的优势(例如:无需全身麻醉、减少手术创伤、适用于肥胖和手术风险高的患者、快速省时的手术过程)。

方法

我们回顾性比较了1968年至1983年在佛罗伦萨我们机构接受治疗的一大系列IB-IIA期宫颈癌患者中根治性阴道手术和根治性腹部手术的长期结果。此外,我们分析了1995年至1998年我们的经验结果,当时我们对48例宫颈癌患者进行了腹膜外盆腔淋巴结清扫术,随后进行了根治性阴道子宫切除术。腹膜外盆腔淋巴结清扫术通过两个小腹部切口(6-7厘米)进行。22例患者(45%)肥胖(BMI>30kg/m²),20例手术风险高。国际妇产科联盟(FIGO)分期为:IB1期18例,IB2期8例,IIA期6例,IIB期12例,IIIB期4例。12例患者接受了新辅助化疗,10例患者接受了术前放疗。30例(62.5%)患者使用全身麻醉,18例(37.5%)患者使用区域麻醉。

结果

就过去的经验而言,在IB期,356例行根治性阴道子宫切除术的患者和288例行根治性腹部子宫切除术加盆腔淋巴结清扫术患者的五年生存率分别为81%和75%(p<0.05)。第一组手术并发症较少,无死亡病例。在IIA期,76例和64例分别行根治性阴道子宫切除术和根治性腹部子宫切除术患者的生存率分别为68%和64%(p=无统计学意义)。就最近的经验而言,腹膜外盆腔淋巴结清扫术每侧的中位手术时间为20分钟(范围15-36分钟)。每位患者中位切除26个淋巴结(范围16-48个)。12例(25%)发现阳性淋巴结。根治性阴道子宫切除术的中位手术时间为40分钟(范围30-65分钟)。腹膜外盆腔淋巴结清扫术的并发症包括:淋巴囊肿5例(10%)和腹膜后血肿1例(2%);均发生在经验初期。根治性阴道子宫切除术的并发症包括:输尿管狭窄1例(2%)和输尿管阴道瘘1例(2%)。所有并发症均发生在术前接受放疗或化疗的患者中。中位住院时间为10天(范围6-20天)。

结论

我们的研究结果表明,我们的腹膜外盆腔淋巴结清扫术技术对接受根治性阴道子宫切除术的宫颈癌患者具有良好的适用性,如我们过去的经验所示,该手术对IB期和IIA期具有较高的治愈率。腹膜外盆腔淋巴结清扫术操作快速、简便、安全,其实施并不损害根治性阴道子宫切除术的优势。我们的经验支持在宫颈癌治疗中继续使用这种腹膜外和阴道联合的方法。此外,三类根治性阴道子宫切除术可根据患者的临床和身体特征调整手术类型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验